https://www.nationaljewish.org/doctors-departments/cj-bathgate
Dr. CJ Bathgate is a clinical health psychologist and Associate Professor of Medicine in the Division of Neurology and Behavioral Health at National Jewish Health in Denver, CO. Dr. Bathgate focuses on the mental health and emotional well-being of adults with cystic fibrosis (CF). Her clinical and research interests include mood, sleep, stress, neurocognition, health behaviors, quality of life, and aging with CF, with particular emphasis on the impact of cystic fibrosis transmembrane conductance regulator (CFTR) modulators and overall well-being.
Dr. Bathgate is the current Chair of the Prioritizing Research in Menta Health Working Group (PRIME) for the Cystic Fibrosis Foundation (CFF) and a CFF Clinical Research Scholars Program (CRSP) recipient. She has been a Principal Investigator or Co-Investigator on numerous CF multisite mental health studies, including the development and testing of the Coping and Learning to Manage Stress with CF (CALM) telehealth program, Promoting Access to Create Hope and Healing (CF-PATCH): A study examining interpersonal violence in CF, the General Mental Health Screener in CF (GEMS-CF), the CF Wellness Program evaluating fatigue, sleep, and physical activity outcomes (CF-Wellness), and the Restarting Triple Therapy with Robust Monitoring for Adverse Events (RETRIAL) study. She is Co-Chair of the Psychosocial Program Planning Committee for the North American CF Conference, a member of the Success with Therapies Research Consortium, and an active collaborator with the CFF’s Mental Health Advisory Committee and European CF Society’s Mental Health Working Group.
Dr. Bathgate was the first graduate of our APA-accredited Clinical Health Psychology doctoral program. In 2014, she was named Outstanding PhD Student of the Year, an honor awarded to a single doctoral student across all PhD programs in UCD’s College of Liberal Arts and Sciences.
Prior to her tenure at UCD, she completed Masters of Arts degree and a Masters of Education degree in Counseling Psychology from Columbia University in 2006 and her Bachelor of Arts degree in psychology from the University of Michigan.
Some of Dr. Bathgate’s recent publications include:
Bathgate CJ, Smith ED, Murphy NH, Quittner AL, Riekert KA, Goralski JL, Holm KE. Stress management reduces severe depression and anxiety symptoms in adults with cystic fibrosis: Results from the coping and learning to manage stress (CALM) intervention. J Cyst Fibros. 2026 Mar 25:S1569-1993(26)00082-2. doi: 10.1016/j.jcf.2026.03.015. Epub ahead of print. PMID: 41887978.
Graziano S, Landau EC, Mitmansgrubert H, Verkleij M, Georgiopoulos AM, Borawska-Kowalczyk U, Smith BA, Bathgate CJ, Quittner AL. Multidimensional Impacts of Elexacaftor/Tezacaftor/Ivacaftor: Comparisons of Physical and Mental Health Providers' Observations in Cystic Fibrosis in Europe and the United States. Pediatr Pulmonol. 2025 Nov;60(11):e71367. doi: 10.1002/ppul.71367. PMID: 41222007.
Bathgate CJ, Fedele DA, Tillman EM, He J, Everhart RS, Reznikov LR, Liu FF, Kirby K, Raffensperger K, Traver K, Riekert KA, Powers SW, Georgiopoulos AM. Elexacaftor/tezacaftor/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation's Prioritizing Research in Mental Health working group. J Cyst Fibros. 2025 Mar;24(2):301-309. doi: 10.1016/j.jcf.2024.11.006. Epub 2024 Nov 26. PMID: 39592379.
Bathgate CJ, Smith ED, Murphy NH, Quittner AL, Riekert KA, Goralski JL, Holm KE. Coping and learning to Manage Stress with cystic fibrosis (CALM): A multisite telehealth randomized controlled trial to reduce depression and anxiety symptoms in adults with cystic fibrosis. J Cyst Fibros. 2025 Mar;24(2):310-318. doi: 10.1016/j.jcf.2024.11.002. Epub 2024 Nov 24. PMID: 39581781.
Bathgate, C., Graziano, S., & Muther, E. (2023). The Role of a Psychologist on the Cystic Fibrosis Care Team. In A. Bush, M. Amaral, J. Davies, N. Simmonds, J. Taylor-Cousar, & S. Ranganathan (Eds.), Hodson and Geddes’ Cystic Fibrosis, 5th Edition. CRC Press, Taylor & Francis Group.
Bathgate, C., Muther, E., Georgiopoulos, A.M., Smith, B., Tillman, L., Graziano, S., Verkleij, M., Lomas, P., & Quittner, A. (2023). Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers. Pediatric Pulmonology. Sep;58(9):2469-2477. doi: 10.1002/ppul.26527. Epub 2023 Jun 2. PMID: 37265418.
Bathgate, C., Hjelm, M., Filigno, S., Smith, B., & Georgiopoulos, A. (2022). Management of Mental Health in Cystic Fibrosis. Clinics in Chest Medicine, 43(4), 791-810. doi: 10.1016/j.ccm.2022.06.014.
Bathgate, C., Kilbourn, K., Murphy, M., Wamboldt, F. & Holm, K. (2021). Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis. Journal of Cystic Fibrosis, S1569-1993 (21) 01326-6. Advance online publication. doi: 10.1016/j.jcf.2021.07.012.
Richards, C., Bathgate, C., Nippins, M., Garton, J., Garlow, G., & Georgiopoulos, A. (2019). What Lifestyle Changes Can I Make To Address My Cystic Fibrosis? In Y. Sher, A. M. Georgiopoulos, & T. A. Stern (Eds.), Facing Cystic Fibrosis: A Guide for Patients and Their Families. Cambridge. MA: MGH Psychiatry Academy.
Bathgate, C. & Edinger, J. (2019). Diagnostic Criteria and Assessment of Sleep Disorders. In J. Savard and M. Ouellet (Eds.), Handbook of Sleep Disorders in Medical Conditions (pp. 3-26). Cambridge, MA: Academic Press.
Bathgate, C., Holm, K., Murphy, N., Kilbourn, K., & Wamboldt, F. (2019). Telehealth cognitive behavioral stress management: Preliminary pilot highlights and challenges. Pediatric Pulmonology, 54 supplement 2, S411.
Khassawneh, B., Bathgate, C., Tsai, Sheila, & Edinger, J. (2018). Neurocognitive Performance in Insomnia Disorder: The Impact of Hyperarousal and Short Sleep Duration. Journal of Sleep Research, 27(6), e12747. doi:10.1111/jsr.12747
Bathgate, C. & Fernandez-Mendoza, J. (2018). Insomnia, Short Sleep Duration, and High Blood Pressure: Recent Evidence and Future Directions for the Prevention and Management of Hypertension, Current Hypertension Reports, 20(6). doi: 10.1007/s11906-018-0850-6.
Bathgate, C., Edinger, J., & Krystal, A. (2017). Insomnia Patients with Objective Short Sleep Duration have a Blunted Response to Cognitive Behavioral Therapy for Insomnia. Sleep, 40(1). doi: 10.1093/sleep/zsw012. PubMed PMID: 28364452.
Bathgate, C., Edinger, J., Wyatt, J., & Krystal, A. (2016). Objective but not subjective short sleep duration associated with increased risk for hypertension in individuals with insomnia. Sleep, 39(5):1037-45. doi: 10.5665/sleep.5748.
Bathgate, C., Edinger, J., Manber, R., Buysse, D., Krystal, A., Thase, M., Wisniewski, S. (2016). Do patients with insomnia and comorbid moderate to severe, persistent depression respond differently to combined depression and insomnia treatment than to those with mild to moderate, less persistent depression? A report from the TRIAD study. Sleep, 39, A200.
Breitborde, N., Woolverton, C., Spencer, D., Bismark, A., Bell, E., Bathgate, C., Norman, K. (2015). Metacognitive skills training enhances computerized cognitive remediation outcomes among individuals with first-episode psychosis. Early Intervention in Psychiatry. doi:10.1111/eip.12289. [ePub ahead of print]"
Kalinka, C., Fincham, F., & Hirsch, A. (2012). A randomized clinical trial of online-biblio relationship education for expectant couples. Journal of Family Psychology, 26(1), 159-164.doi: 10.1037/a0026398.
Kaplan, P., Danko, C., Kalinka, C., & Cejka. A. (2012). A developmental decline in the learning-promoting effects of infant-directed speech for infants of mothers with chronically elevated symptoms of depression. Infant Behavior and Development, 35(3), 369-379, doi: 10.1016/j.infbeh.2012.02.009.
Kaplan, P., Danko, C., Diaz, A., & Kalinka, C. (2011). An associative learning deficit in one-year-old infants of depressed mothers: Role of depression duration. Infant Behavior and Development, 34(1), 35-44. doi:10.1016/j.infbeh.2010.07.014.